These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31629472)

  • 41. Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice.
    Shaw AM; Irani BG; Moore MC; Haskell-Luevano C; Millard WJ
    Peptides; 2005 Oct; 26(10):1720-7. PubMed ID: 16005545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice.
    Chang TC; Chiang H; Lai YH; Huang YL; Huang HC; Liang YC; Liu HK; Huang C
    BMC Complement Altern Med; 2019 Dec; 19(1):368. PubMed ID: 31836013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
    Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockout studies defining different roles for melanocortin receptors in energy homeostasis.
    Butler AA; Cone RD
    Ann N Y Acad Sci; 2003 Jun; 994():240-5. PubMed ID: 12851322
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voluntary exercise prevents the obese and diabetic metabolic syndrome of the melanocortin-4 receptor knockout mouse.
    Haskell-Luevano C; Schaub JW; Andreasen A; Haskell KR; Moore MC; Koerper LM; Rouzaud F; Baker HV; Millard WJ; Walter G; Litherland SA; Xiang Z
    FASEB J; 2009 Feb; 23(2):642-55. PubMed ID: 18971258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity.
    Watson E; Hahm S; Mizuno TM; Windsor J; Montgomery C; Scherer PE; Mobbs CV; Salton SR
    Endocrinology; 2005 Dec; 146(12):5151-63. PubMed ID: 16141392
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia.
    Tallam LS; Stec DE; Willis MA; da Silva AA; Hall JE
    Hypertension; 2005 Aug; 46(2):326-32. PubMed ID: 16027245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
    Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
    Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low-Density Lipoprotein Receptor-Related Protein-1 Protects Against Hepatic Insulin Resistance and Hepatic Steatosis.
    Ding Y; Xian X; Holland WL; Tsai S; Herz J
    EBioMedicine; 2016 May; 7():135-45. PubMed ID: 27322467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
    Komiya C; Tsuchiya K; Shiba K; Miyachi Y; Furuke S; Shimazu N; Yamaguchi S; Kanno K; Ogawa Y
    PLoS One; 2016; 11(3):e0151511. PubMed ID: 26977813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model.
    Orime K; Shirakawa J; Togashi Y; Tajima K; Inoue H; Nagashima Y; Terauchi Y
    Eur J Pharmacol; 2016 Feb; 772():22-32. PubMed ID: 26724391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic lipase deficiency produces glucose intolerance, inflammation and hepatic steatosis.
    Andrés-Blasco I; Herrero-Cervera A; Vinué Á; Martínez-Hervás S; Piqueras L; Sanz MJ; Burks DJ; González-Navarro H
    J Endocrinol; 2015 Dec; 227(3):179-91. PubMed ID: 26423094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deletion of the MC4R gene in a 9-year-old obese boy.
    Turner L; Gregory A; Twells L; Gregory D; Stavropoulos DJ
    Child Obes; 2015 Apr; 11(2):219-23. PubMed ID: 25747306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
    Allen J; Zhang J; Quickel MD; Kennett M; Patterson AD; Hankey-Giblin PA
    J Proteome Res; 2018 Sep; 17(9):3268-3280. PubMed ID: 30091925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.
    Masuda S; Fujishima Y; Maeda N; Tsugawa-Shimizu Y; Nakamura Y; Tanaka Y; Obata Y; Fukuda S; Nagao H; Kita S; Nishizawa H; Shimomura I
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E239-E250. PubMed ID: 30457913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity.
    Phan LK; Chung WK; Leibel RL
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E611-20. PubMed ID: 16638826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
    Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2.
    Kim HM; Kim YM; Huh JH; Lee ES; Kwon MH; Lee BR; Ko HJ; Chung CH
    PLoS One; 2017; 12(6):e0179204. PubMed ID: 28598982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.